ArticleThe Journal of infection2022
Resistance mutations in SARS-CoV-2 omicron variant after tixagevimab-cilgavimab treatment.
Camille Vellas et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it